Moti to invest $35m in joint pharmaceutical deal

Taurai Mangudhla recently in Kwekwe One of Zimbabwe’s largest investors, the Moti Group plans to invest over $35 million in a joint pharmaceutical manufacturing and distribution deal with a reputable pharmaceutical company as part of the group’s diversification efforts. Moti Group chairman Zunaid Moti yesterday told Business Times in an interview the pharmaceutical deal will…